Clinical Trial Update: Long-term Study in Patients Under Anti-retroviral Combination Therapy Switching to Viramune®

View source ↗

Summary

This trial update reports on a long-term study of patients on combination antiretroviral therapy who switch to Viramune (nevirapine); the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Viramune (Nevirapine)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: HIV Infections | Status: COMPLETED